EUVIMEDEUVIMED entdecken
Vergleichsstudie

Translocator Protein 18 kDa–Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis: A Prospective Head-to-Head Comparison with 18 F-FDG

Min Zhang, Jinyi Qian, Yingqi Jia, Shuyi Yu, Yuying Fan, Haoyu Pan, Xiaohan Wei, Zhixia Yang, Shiyan Gu, Jianzhou Wu, Tiancheng Zhou, Yue Wang und 6 weitere

Journal of Nuclear Medicine · 2026

DOI: 10.2967/jnumed.125.270910 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Min Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Ruijn Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Receptors, GABA, Positron Emission Tomography Computed Tomography, Vasculitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of vascular inflammation in large-vessel vasculitis (LVV) remains challenging, especially in patients with normal inflammatory markers or inconclusive 18F-FDG PET findings. The translocator protein 18 kDa (TSPO), a marker of inflammatory process, has emerged as a promising molecular target for imaging vascular inflammation in LVV.

Methods

We prospectively enrolled 11 treatment-naïve patients with LVV and 11 healthy controls who underwent 90-min dynamic total-body 18F-DPA714 PET/CT imaging. Ten patients also underwent 18F-FDG PET/CT for direct comparison. We assessed SUVs, lesion-to-background ratios, and kinetic parameters using a 2-tissue compartment model (2T4K_vB). Peripheral blood samples from patients and controls were analyzed by flow cytometry to characterize the cellular sources of the TSPO signal.

Results

18F-DPA714 PET revealed that tracer uptake in patients with LVV was significantly higher than that in healthy controls (median SUVmean, 0.81 [interquartile range (IQR), 0.64-0.98] vs. 0.54 [IQR, 0.44-0.64]; P = 0.000-0.043). Kinetic modeling using the 2T4K_vB compartment model further confirmed the specificity of TSPO binding, demonstrating elevated parameters of irreversible binding and total distribution volume in inflamed vascular segments. In head-to-head comparisons, 18F-DPA714 showed modestly but significantly higher vessel wall-to-lumen contrast relative to 18F-FDG (lesion-to-background ratio, 1.02 [IQR, 1.00-1.15] vs. 1.00 [IQR, 0.98-1.01]; P = 0.005-0.021). Among patients with relatively lower C-reactive protein levels (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Receptors, GABAPositron Emission Tomography Computed TomographyVasculitisWhole Body ImagingPositron-Emission TomographyHumansMaleFemaleMiddle AgedProspective StudiesAgedInflammationAdultPyrimidinesPyrazolesTetrazolesRadiopharmaceuticals

Stichwörter der Autor:innen

TSPOinflammation imaginglarge-vessel vasculitistotal-body PET/CT

Substanzen

Fluorodeoxyglucose F18TSPO protein, humanReceptors, GABAPyrimidinesN,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamidePyrazolesTetrazolesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Ruijn Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and.
  • Department of Hypertension, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Nuclear Medicine, Ruijn Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; lb10363@rjh.com.cn shihui_sjtu@sina.com.
  • Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and lb10363@rjh.com.cn shihui_sjtu@sina.com.

Zitieren

APA

Zhang, M., Qian, J., Jia, Y., Yu, S., Fan, Y., Pan, H., Wei, X., Yang, Z., Gu, S., Wu, J., Zhou, T., Wang, Y., Wang, J., Chen, Y., Teng, J., Yang, C., Li, B., & Shi, H. (2026). Translocator Protein 18 kDa–Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis: A Prospective Head-to-Head Comparison with 18 F-FDG. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270910

Vancouver

Zhang M, Qian J, Jia Y, Yu S, Fan Y, Pan H, et al. Translocator Protein 18 kDa–Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis: A Prospective Head-to-Head Comparison with 18 F-FDG. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.270910

BibTeX
@article{Zhang2026,
  author = {Zhang, Min and Qian, Jinyi and Jia, Yingqi and Yu, Shuyi and Fan, Yuying and Pan, Haoyu and Wei, Xiaohan and Yang, Zhixia and Gu, Shiyan and Wu, Jianzhou and Zhou, Tiancheng and Wang, Yue and Wang, Jin and Chen, Yi and Teng, Jialin and Yang, Chengde and Li, Biao and Shi, Hui},
  title = {Translocator Protein 18 kDa–Targeted Total-Body PET Imaging Reveals Immune-Specific Vascular Inflammation in Large-Vessel Vasculitis: A Prospective Head-to-Head Comparison with 18 F-FDG},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  doi = {10.2967/jnumed.125.270910}
}
Kostenlos starten →